Alyeska Investment Group
GILD icon

Alyeska Investment Group’s Gilead Sciences GILD Stock Holding History

Alyeska Investment Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-525,000
Closed -$51.5M – 516
2015
Q1 		$51.5M Buy
+525,000
New +$53.3M 0.71% 17
2013
Q4 		– Sell
-55,000
Closed -$3.46M – 337
2013
Q3 		$3.46M Buy
+55,000
New +$3.29M 0.14% 182

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Alyeska Investment Group's GILD Position: Q3 2025 in Review

Alyeska Investment Group sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 44,661 shares — an estimated $4.95M sold.

Alyeska Investment Group first reported a position in GILD in Q2 2013 and held it in 14 quarters. The position peaked at $101M in Q1 2016. 2,027 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Alyeska Investment Group reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 44,661 Gilead Sciences shares in Q3 2025, an estimated $4.95M.
  • Alyeska Investment Group first reported a position in Gilead Sciences in Q2 2013 and held it in 14 quarters.
  • Alyeska Investment Group's Gilead Sciences position peaked at $101M in Q1 2016.
  • 2,027 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Alyeska Investment Group's 13F filing for Q3 2025, filed 17 Nov 2025.